IOPROMIDE

IOPROMIDE was reported 4182 times

IOPROMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONTRAST ENCEPHALOPATHY 85 0.3080
1 ARTERIAL BYPASS THROMBOSIS 1 0.2500
2 ADMINISTRATION SITE JOINT MOVEMENT IMPAIRMENT 1 0.2500
3 ENCEPHALOPATHY ALLERGIC 1 0.2000
4 PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME 24 0.1690
5 OXYGEN SATURATION IMMEASURABLE 17 0.1545
6 CAROTID PULSE ABNORMAL 8 0.1481
7 ALVEOLAR LUNG DISEASE 24 0.1263
8 CONTRAST MEDIA ALLERGY 214 0.1167
9 BRONCHIAL MUCOSA HYPERAEMIA 1 0.1111
10 CAROTID PULSE DECREASED 4 0.0889
11 BLOOD PRESSURE IMMEASURABLE 83 0.0541
12 URTICARIA VESICULOSA 2 0.0526
13 CONTRAST MEDIA REACTION 117 0.0495
14 SKIN TEMPERATURE INCREASED 4 0.0471
15 SUBMAXILLARY GLAND ENLARGEMENT 3 0.0417
16 CLINICAL DEATH 2 0.0385
17 AMAUROSIS 32 0.0380
18 CRAMP-FASCICULATION SYNDROME 1 0.0333
19 NONINFECTIVE SIALOADENITIS 5 0.0314
20 TYPE II HYPERSENSITIVITY 3 0.0252
21 HYPERAEMIA 47 0.0238
22 DILATED PORES 2 0.0220
23 DIFFUSE ALVEOLAR DAMAGE 25 0.0217
24 PERIPHERAL PULSE DECREASED 2 0.0206
25 LARYNGEAL DISCOMFORT 13 0.0204
26 CONJUNCTIVAL OEDEMA 18 0.0175
27 NASAL OBSTRUCTION 31 0.0165
28 CIRCUMORAL SWELLING 2 0.0156
29 RESPIRATORY RATE INCREASED 135 0.0152
30 CONVULSIONS LOCAL 3 0.0152
31 ANAPHYLACTIC SHOCK 389 0.0151
32 ANAESTHESIA ORAL 1 0.0149
33 SUSPECTED PRODUCT QUALITY ISSUE 26 0.0142
34 HYPOTENSIVE CRISIS 2 0.0139
35 FOAMING AT MOUTH 28 0.0139
36 PO2 INCREASED 7 0.0138
37 APPLICATION SITE EXTRAVASATION 1 0.0133
38 PUPILLARY LIGHT REFLEX TESTS ABNORMAL 4 0.0129
39 PATIENT UNCOOPERATIVE 6 0.0127
40 SIALOADENITIS 17 0.0125
41 ADRENERGIC SYNDROME 1 0.0123
42 LARYNGEAL OEDEMA 76 0.0123
43 NEPHROPATHY TOXIC 133 0.0118
44 LIP PRURITUS 10 0.0117
45 PULSE ABNORMAL 28 0.0116
46 CIRCUMORAL OEDEMA 4 0.0115
47 TRACHEAL OBSTRUCTION 3 0.0114
48 DIFFUSE VASCULITIS 1 0.0111
49 ATRIAL HYPERTROPHY 1 0.0111
50 LIVIDITY 4 0.0109
51 AGONAL RESPIRATION 3 0.0106
52 CILIARY HYPERAEMIA 1 0.0105
53 BLOOD CORTICOTROPHIN ABNORMAL 1 0.0104
54 BINOCULAR EYE MOVEMENT DISORDER 3 0.0104
55 PULSE ABSENT 48 0.0101
56 REDUCED FACIAL EXPRESSION 10 0.0099
57 PUPILLARY REFLEX IMPAIRED 18 0.0097
58 SHIFT TO THE LEFT 2 0.0097
59 SKIN TEST POSITIVE 9 0.0096
60 CONTRAST MEDIA DEPOSITION 3 0.0095
61 DEFECT CONDUCTION INTRAVENTRICULAR 3 0.0093
62 MOUTH BREATHING 4 0.0092
63 CONJUNCTIVAL HYPERAEMIA 32 0.0090
64 SUFFOCATION FEELING 22 0.0089
65 CERVIX DYSTOCIA 1 0.0088
66 DECEREBRATION 1 0.0088
67 EYELID OEDEMA 102 0.0088
68 PANCREATIC NECROSIS 3 0.0086
69 SLOW RESPONSE TO STIMULI 11 0.0085
70 SKIN FIBROSIS 4 0.0083
71 CYANOSIS 130 0.0083
72 ORAL DISCHARGE 3 0.0082
73 EYE OEDEMA 20 0.0081
74 TONGUE PRURITUS 7 0.0081
75 SHOCK SYMPTOM 3 0.0081
76 RESPIRATORY TRACT OEDEMA 6 0.0081
77 LIP OEDEMA 34 0.0080
78 INDIFFERENCE 6 0.0080
79 INCORRECT DRUG ADMINISTRATION RATE 34 0.0080
80 NASAL PRURITUS 10 0.0080
81 ORBITAL OEDEMA 4 0.0079
82 UPPER AIRWAY OBSTRUCTION 7 0.0079
83 CYANOSIS CENTRAL 2 0.0077
84 EOSINOPHILIC PNEUMONIA 24 0.0076
85 HEMIANAESTHESIA 6 0.0075
86 AMAUROSIS FUGAX 8 0.0074
87 SCLERAL HYPERAEMIA 5 0.0073
88 MACROGLOSSIA 4 0.0073
89 USE OF ACCESSORY RESPIRATORY MUSCLES 3 0.0073
90 COMPUTERISED TOMOGRAM 1 0.0072
91 EYELID THICKENING 2 0.0070
92 ANAL SPHINCTER ATONY 3 0.0070
93 SINUS RHYTHM 3 0.0069
94 SNEEZING 154 0.0069
95 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 4 0.0068
96 TACHYPNOEA 93 0.0068
97 TYPE I HYPERSENSITIVITY 24 0.0068
98 CARDIOVASCULAR INSUFFICIENCY 11 0.0068
99 PAPULE 47 0.0067
100 NASAL OEDEMA 12 0.0066
101 DYSPHORIA 33 0.0065
102 ADAMS-STOKES SYNDROME 1 0.0065
103 PHARYNGEAL HYPOAESTHESIA 6 0.0065
104 LIP ERYTHEMA 5 0.0063
105 KOUNIS SYNDROME 14 0.0062
106 IODINE ALLERGY 2 0.0060
107 DIASTOLIC HYPOTENSION 1 0.0059
108 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 46 0.0059
109 VITAL FUNCTIONS ABNORMAL 5 0.0058
110 ASPHYXIA 47 0.0058
111 FACE OEDEMA 97 0.0057
112 BLOOD PRESSURE DECREASED 376 0.0057
113 GLASSY EYES 4 0.0056
114 CORONARY ARTERY INSUFFICIENCY 2 0.0056
115 APALLIC SYNDROME 4 0.0055
116 BRONCHOSTENOSIS 3 0.0055
117 CEREBRAL VENTRICULAR RUPTURE 1 0.0055
118 RESUSCITATION 9 0.0054
119 ARTERIOVENOUS FISTULA SITE HAEMORRHAGE 1 0.0053
120 TONGUE OEDEMA 20 0.0052
121 PO2 DECREASED 6 0.0052
122 LARYNGEAL STENOSIS 3 0.0052
123 BREAST OEDEMA 1 0.0052
124 CATHETER SITE VESICLES 1 0.0051
125 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 11 0.0050
126 EOSINOPHIL PERCENTAGE DECREASED 1 0.0050
127 OROPHARYNGEAL DISCOMFORT 45 0.0050
128 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 13 0.0050
129 BRONCHIAL FISTULA 1 0.0050
130 IIIRD NERVE PARALYSIS 4 0.0049
131 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 4 0.0049
132 EAR PRURITUS 17 0.0048
133 HYPERAMMONAEMIA 24 0.0048
134 ORAL PRURITUS 11 0.0048
135 SENSATION OF FOREIGN BODY 40 0.0047
136 JOINT CONTRACTURE 5 0.0047
137 SWELLING OF EYELID 29 0.0046
138 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 15 0.0045
139 ACID BASE BALANCE ABNORMAL 1 0.0045
140 ALLERGY TEST POSITIVE 2 0.0044
141 OXYGEN SATURATION DECREASED 248 0.0044
142 EPIDERMOLYSIS 2 0.0043
143 UNRESPONSIVE TO STIMULI 112 0.0043
144 OEDEMA MOUTH 14 0.0043
145 ELECTROCARDIOGRAM Q WAVE ABNORMAL 1 0.0043
146 AIR EMBOLISM 2 0.0042
147 VEIN RUPTURE 7 0.0042
148 CEREBROVASCULAR INSUFFICIENCY 1 0.0041
149 BLINDNESS CORTICAL 2 0.0041
150 CARDIAC FIBRILLATION 6 0.0041
151 FIXED ERUPTION 7 0.0041
152 SKIN OEDEMA 4 0.0040
153 BRAIN HYPOXIA 4 0.0040
154 PULSE PRESSURE DECREASED 2 0.0039
155 DRAIN PLACEMENT 1 0.0039
156 ANAPHYLACTOID REACTION 16 0.0039
157 GRIMACING 3 0.0038
158 STRIDOR 11 0.0037
159 GENERALISED ERYTHEMA 21 0.0037
160 SKIN TIGHTNESS 17 0.0036
161 URTICARIA CHRONIC 2 0.0036
162 COLD SWEAT 62 0.0035
163 AVERSION 1 0.0035
164 LOCALISED OEDEMA 16 0.0035
165 NASAL MUCOSAL DISORDER 2 0.0034
166 IRREGULAR BREATHING 2 0.0034
167 BLOOD PRESSURE DIASTOLIC DECREASED 25 0.0034
168 PUSTULE 8 0.0034
169 EOSINOPHILIC PNEUMONIA CHRONIC 1 0.0034
170 LARYNGOSPASM 9 0.0033
171 NEPHROGENIC SYSTEMIC FIBROSIS 10 0.0033
172 PALLOR 89 0.0033
173 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 84 0.0033
174 URTICARIA 545 0.0032
175 URINARY INCONTINENCE 92 0.0031
176 RUPTURED CEREBRAL ANEURYSM 2 0.0031
177 SUBCUTANEOUS EMPHYSEMA 3 0.0031
178 ALOPECIA TOTALIS 1 0.0030
179 BLOOD PRESSURE DIASTOLIC INCREASED 14 0.0030
180 ACUTE PULMONARY OEDEMA 17 0.0030
181 ADMINISTRATION SITE EXTRAVASATION 3 0.0030
182 ARRHYTHMIC STORM 1 0.0030
183 GENERALISED OEDEMA 37 0.0030
184 ACUTE LEFT VENTRICULAR FAILURE 2 0.0030
185 GAZE PALSY 5 0.0029
186 MILIARIA 5 0.0029
187 RASH MACULO-PAPULAR 63 0.0028
188 ELECTROCARDIOGRAM ST-T CHANGE 2 0.0028
189 PCO2 INCREASED 2 0.0028
190 TRYPTASE INCREASED 2 0.0028
191 ANAL INCONTINENCE 25 0.0028
192 ANAPHYLACTIC REACTION 151 0.0027
193 DISORGANISED SPEECH 5 0.0027
194 COMA HEPATIC 2 0.0027
195 PERIORBITAL OEDEMA 14 0.0027
196 HEPATIC ENCEPHALOPATHY 25 0.0027
197 THROAT CLEARING 10 0.0027
198 BRONCHOSPASM 38 0.0027
199 HYPOAESTHESIA ORAL 40 0.0027
200 ANISOCORIA 1 0.0026
201 BREATH HOLDING 1 0.0026
202 QRS AXIS ABNORMAL 2 0.0026
203 CAPILLARY DISORDER 1 0.0026
204 INFUSION SITE EXTRAVASATION 16 0.0026
205 PROCEDURAL NAUSEA 2 0.0025
206 ELECTROCARDIOGRAM T WAVE PEAKED 1 0.0025
207 PALATAL OEDEMA 3 0.0024
208 HYDROTHORAX 2 0.0024
209 PERIPHERAL COLDNESS 33 0.0024
210 ALTERED STATE OF CONSCIOUSNESS 52 0.0024
211 INFUSION SITE OEDEMA 2 0.0024
212 LIVEDO RETICULARIS 5 0.0024
213 GLOMERULAR FILTRATION RATE DECREASED 29 0.0024
214 CAROTID ARTERY DISSECTION 1 0.0023
215 BLOOD PH DECREASED 4 0.0023
216 GASTROINTESTINAL HYPERMOTILITY 1 0.0023
217 EXOPHTHALMOS 5 0.0023
218 SINUS ARRHYTHMIA 3 0.0023
219 EOSINOPHILIA 40 0.0023
220 FACIAL NERVE DISORDER 1 0.0023
221 MOUTH SWELLING 13 0.0023
222 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 1 0.0022
223 ENLARGED UVULA 1 0.0022
224 HEART RATE DECREASED 78 0.0022
225 THROAT TIGHTNESS 60 0.0022
226 BLOOD PRESSURE SYSTOLIC DECREASED 10 0.0022
227 BONE INFARCTION 1 0.0022
228 PRURIGO 2 0.0022
229 VENTRICULAR FIBRILLATION 24 0.0022
230 CEREBRAL HYPOPERFUSION 1 0.0021
231 BRONCHIAL OBSTRUCTION 3 0.0021
232 SKIN HYPERTROPHY 6 0.0021
233 TRISMUS 11 0.0021
234 ANAPHYLACTOID SHOCK 1 0.0021
235 INTENSIVE CARE 3 0.0021
236 PCO2 DECREASED 2 0.0021
237 LIP SWELLING 69 0.0021
238 RALES 12 0.0021
239 EYELID RASH 2 0.0020
240 ERYTHEMA OF EYELID 11 0.0020
241 SPUTUM RETENTION 2 0.0020
242 PHARYNGEAL OEDEMA 31 0.0020
243 ABORTION THREATENED 1 0.0020
244 MENTAL FATIGUE 3 0.0020
245 SHOCK 46 0.0020
246 LOSS OF CONSCIOUSNESS 255 0.0020
247 MUSCLE CONTRACTURE 4 0.0020
248 DYSPHONIA 113 0.0019
249 ABDOMINAL INJURY 1 0.0019
250 ERYTHEMA 394 0.0019
251 RASH ERYTHEMATOUS 91 0.0019
252 OEDEMA MUCOSAL 2 0.0019
253 BLOOD PRESSURE SYSTOLIC INCREASED 37 0.0019
254 NON-CARDIOGENIC PULMONARY OEDEMA 2 0.0019
255 EAR SWELLING 4 0.0019
256 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
257 BRAIN MIDLINE SHIFT 1 0.0019
258 FAECAL VOMITING 1 0.0019
259 LANGUAGE DISORDER 4 0.0018
260 CHEILITIS 10 0.0018
261 BRADYPHRENIA 12 0.0018
262 CONJUNCTIVAL HAEMORRHAGE 7 0.0018
263 HENOCH-SCHONLEIN PURPURA 4 0.0018
264 OXYGEN THERAPY 3 0.0018
265 BREATH SOUNDS ABNORMAL 9 0.0018
266 ELECTROCARDIOGRAM T WAVE INVERSION 4 0.0018
267 THROAT IRRITATION 81 0.0018
268 FACIAL SPASM 2 0.0018
269 BODY TINEA 1 0.0018
270 MYOCARDIAL INJURY 2 0.0018
271 CHEST DISCOMFORT 180 0.0018
272 BLOOD FIBRINOGEN DECREASED 2 0.0018
273 LICHENOID KERATOSIS 4 0.0017
274 TEMPERATURE INTOLERANCE 18 0.0017
275 ENANTHEMA 1 0.0017
276 PALMAR ERYTHEMA 2 0.0017
277 PRURITUS ALLERGIC 2 0.0017
278 HYPORESPONSIVE TO STIMULI 2 0.0017
279 SENSE OF OPPRESSION 2 0.0017
280 ANGIOEDEMA 75 0.0017
281 AMBLYOPIA 1 0.0017
282 UPPER RESPIRATORY TRACT INFLAMMATION 2 0.0017
283 EMBOLISM ARTERIAL 2 0.0017
284 AURICULAR SWELLING 1 0.0017
285 ACUTE PSYCHOSIS 4 0.0016
286 RESPIRATORY RATE DECREASED 5 0.0016
287 LIP DISCOLOURATION 2 0.0016
288 GASTROINTESTINAL EROSION 1 0.0016
289 BAND SENSATION 2 0.0016
290 EXTREMITY CONTRACTURE 1 0.0016
291 PHLEBITIS 8 0.0016
292 RESPIRATORY ARREST 43 0.0016
293 SKIN WARM 9 0.0015
294 ALLERGIC OEDEMA 1 0.0015
295 PHARYNGEAL SWELLING 15 0.0015
296 RASH PAPULAR 34 0.0015
297 HEART RATE INCREASED 150 0.0015
298 EMBOLIC CEREBRAL INFARCTION 1 0.0015
299 DEFAECATION DISORDER 1 0.0015
300 WRONG PATIENT RECEIVED MEDICATION 4 0.0015
301 CUTANEOUS SYMPTOM 1 0.0015
302 ISCHAEMIC HEPATITIS 2 0.0015
303 HYPOVOLAEMIC SHOCK 7 0.0015
304 TYPE IV HYPERSENSITIVITY REACTION 4 0.0015
305 QUADRIPLEGIA 3 0.0015
306 CHOKING SENSATION 8 0.0014
307 RHONCHI 2 0.0014
308 SKIN INDURATION 3 0.0014
309 HYPOPNOEA 5 0.0014
310 PETECHIAE 15 0.0014
311 PULSELESS ELECTRICAL ACTIVITY 6 0.0014
312 HEART RATE ABNORMAL 8 0.0014
313 APNOEA 11 0.0014
314 TONIC CONVULSION 2 0.0014
315 CARDIO-RESPIRATORY ARREST 59 0.0014
316 AUDITORY DISORDER 2 0.0014
317 SALIVARY HYPERSECRETION 14 0.0014
318 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
319 COMA SCALE ABNORMAL 4 0.0014
320 CLONIC CONVULSION 1 0.0014
321 BLOOD CREATINE INCREASED 6 0.0014
322 CARDIAC ARREST 111 0.0013
323 RESPIRATORY DISTRESS 37 0.0013
324 RESTLESSNESS 49 0.0013
325 HYPERHIDROSIS 172 0.0013
326 HAEMORRHAGIC TRANSFORMATION STROKE 2 0.0013
327 FLUSHING 135 0.0013
328 MYOGLOBIN BLOOD INCREASED 2 0.0013
329 COAGULATION TEST ABNORMAL 1 0.0013
330 BRAIN DEATH 4 0.0013
331 ORAL MUCOSAL ERYTHEMA 2 0.0013
332 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 1 0.0013
333 OPHTHALMOPLEGIA 2 0.0013
334 EYELID FUNCTION DISORDER 1 0.0013
335 OCULAR HYPERAEMIA 60 0.0013
336 PHARYNGEAL PARAESTHESIA 2 0.0013
337 PRURITUS 481 0.0013
338 STUPOR 4 0.0012
339 EXCESSIVE GRANULATION TISSUE 1 0.0012
340 RASH PUSTULAR 9 0.0012
341 PARKINSONISM 12 0.0012
342 RESPIRATORY ALKALOSIS 2 0.0012
343 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 1 0.0012
344 VASOPLEGIA SYNDROME 2 0.0012
345 LISTLESS 4 0.0012
346 CONTRAINDICATED PRODUCT PRESCRIBED 2 0.0012
347 BRAIN OEDEMA 15 0.0012
348 SPLEEN DISORDER 2 0.0012
349 HYPERPYREXIA 5 0.0012
350 NASAL CONGESTION 69 0.0012
351 MYDRIASIS 15 0.0012
352 CHILLS 137 0.0012
353 RASH PRURITIC 63 0.0012
354 COMPARTMENT SYNDROME 3 0.0011
355 FEELING COLD 32 0.0011
356 EXTREMITY NECROSIS 2 0.0011
357 CARDIAC OUTPUT DECREASED 1 0.0011
358 OLIGURIA 7 0.0011
359 HAEMORRHAGE SUBCUTANEOUS 4 0.0011
360 SKIN DISCOMFORT 3 0.0011
361 BRADYPNOEA 3 0.0011
362 CATARRH 1 0.0011
363 DERMATITIS BULLOUS 8 0.0011
364 DYSPNOEA 621 0.0011
365 COLOUR BLINDNESS 1 0.0011
366 DEPRESSED LEVEL OF CONSCIOUSNESS 43 0.0011
367 BLINDNESS TRANSIENT 8 0.0011
368 EYE SWELLING 40 0.0011
369 SWELLING FACE 70 0.0011
370 OXYGEN SATURATION ABNORMAL 3 0.0011
371 HYPOPROTEINAEMIA 2 0.0011
372 DRUG DISPENSED TO WRONG PATIENT 1 0.0010
373 HYPERTHERMIA 8 0.0010
374 FEELING HOT 64 0.0010
375 FOREIGN BODY IN EYE 1 0.0010
376 FAECAL INCONTINENCE 5 0.0010
377 UPPER RESPIRATORY TRACT CONGESTION 3 0.0010
378 BLADDER CATHETERISATION 1 0.0010
379 CROSS SENSITIVITY REACTION 1 0.0010
380 EPIGASTRIC DISCOMFORT 4 0.0010
381 EYE MOVEMENT DISORDER 7 0.0010
382 DEVICE RELATED THROMBOSIS 1 0.0010
383 CARDIAC ANEURYSM 1 0.0010
384 HYPOTONIA 10 0.0010
385 DERMATITIS EXFOLIATIVE 5 0.0010
386 CIRCULATORY COLLAPSE 17 0.0010
387 CARDIAC DISCOMFORT 2 0.0010
388 AUTONOMIC NEUROPATHY 1 0.0010
389 HYPOTHERMIA 10 0.0010
390 EXTRAVASATION 4 0.0010
391 CEREBRAL ISCHAEMIA 5 0.0010
392 ALVEOLITIS ALLERGIC 1 0.0010
393 TONGUE DISORDER 7 0.0010
394 EYELIDS PRURITUS 3 0.0010
395 HYPOTENSION 193 0.0010
396 APHASIA 29 0.0010
397 SYNCOPE 96 0.0010
398 FOREIGN BODY IN THROAT 3 0.0010
399 EYE PRURITUS 32 0.0010
400 PHARYNGEAL ERYTHEMA 2 0.0009
401 POOR PERIPHERAL CIRCULATION 4 0.0009
402 CEREBRAL ARTERY OCCLUSION 1 0.0009
403 SKIN SWELLING 8 0.0009
404 CARDIAC FAILURE ACUTE 6 0.0009
405 SUPRAVENTRICULAR EXTRASYSTOLES 3 0.0009
406 DISTRIBUTIVE SHOCK 2 0.0009
407 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
408 CORTISOL DECREASED 1 0.0009
409 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
410 RESPIRATION ABNORMAL 6 0.0009
411 ADMINISTRATION SITE PAIN 1 0.0009
412 MICTURITION DISORDER 3 0.0009
413 NEUROLOGICAL DECOMPENSATION 2 0.0009
414 PRESYNCOPE 21 0.0009
415 DERMATITIS EXFOLIATIVE GENERALISED 3 0.0009
416 SKIN REACTION 12 0.0009
417 GLOSSITIS 3 0.0008
418 ACUTE LUNG INJURY 1 0.0008
419 PRURITUS GENERALISED 18 0.0008
420 ANURIA 7 0.0008
421 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
422 INTRAVENTRICULAR HAEMORRHAGE 2 0.0008
423 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1 0.0008
424 ALLERGY TO CHEMICALS 1 0.0008
425 LACRIMATION INCREASED 24 0.0008
426 VASODILATATION 2 0.0008
427 TOXIC ENCEPHALOPATHY 4 0.0008
428 APHONIA 11 0.0008
429 CARDIOVASCULAR DISORDER 20 0.0008
430 ACIDOSIS 6 0.0008
431 COMMUNICATION DISORDER 3 0.0008
432 OESOPHAGEAL ULCER 3 0.0008
433 DRUG CLEARANCE DECREASED 1 0.0008
434 TACHYCARDIA 68 0.0008
435 FOREIGN BODY IN RESPIRATORY TRACT 1 0.0008
436 BLOOD LACTIC ACID INCREASED 4 0.0008
437 BLOOD PRESSURE INCREASED 116 0.0008
438 AZOTAEMIA 3 0.0008
439 YAWNING 2 0.0007
440 SEIZURE 86 0.0007
441 ENURESIS 3 0.0007
442 MULTIPLE ORGAN DYSFUNCTION SYNDROME 21 0.0007
443 EAR CONGESTION 2 0.0007
444 PALPITATIONS 86 0.0007
445 TIC 4 0.0007
446 INJECTION SITE EXTRAVASATION 9 0.0007
447 ORAL DISCOMFORT 10 0.0007
448 OBSTRUCTIVE AIRWAYS DISORDER 8 0.0007
449 ACUTE KIDNEY INJURY 110 0.0007
450 CHOKING 14 0.0007
451 COMA 34 0.0007
452 ENDOTRACHEAL INTUBATION 2 0.0007
453 CULTURE URINE POSITIVE 1 0.0007
454 PERIORBITAL SWELLING 4 0.0007
455 SWOLLEN TONGUE 22 0.0007
456 BLOOD PRESSURE ABNORMAL 14 0.0007
457 TUMOUR HAEMORRHAGE 2 0.0007
458 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 12 0.0007
459 CARDIOGENIC SHOCK 10 0.0007
460 LIP PAIN 2 0.0007
461 PHARYNGEAL DISORDER 2 0.0007
462 PARAESTHESIA ORAL 10 0.0007
463 PARAPLEGIA 2 0.0007
464 VOMITING PROJECTILE 2 0.0007
465 WHEEZING 41 0.0007
466 MONOPLEGIA 3 0.0007
467 DYSPNOEA AT REST 2 0.0007
468 HYPERVENTILATION 4 0.0007
469 GASTROINTESTINAL NECROSIS 2 0.0007
470 STRABISMUS 2 0.0007
471 DARK CIRCLES UNDER EYES 1 0.0007
472 COCCYDYNIA 1 0.0007
473 ACUTE MYOCARDIAL INFARCTION 20 0.0007
474 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
475 BLOOD PARATHYROID HORMONE DECREASED 1 0.0007
476 ANGIOPLASTY 1 0.0007
477 BLOOD THYROID STIMULATING HORMONE DECREASED 3 0.0007
478 BLISTER 37 0.0007
479 MUSCLE TWITCHING 15 0.0007
480 GASTRITIS EROSIVE 3 0.0006
481 ERYTHEMA MULTIFORME 6 0.0006
482 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
483 SINUS TACHYCARDIA 9 0.0006
484 ORTHOPNOEA 2 0.0006
485 VOMITING 293 0.0006
486 HEAD DISCOMFORT 11 0.0006
487 SKIN EROSION 2 0.0006
488 DRUG ERUPTION 11 0.0006
489 SINUS BRADYCARDIA 6 0.0006
490 RHINITIS 5 0.0006
491 POSTURE ABNORMAL 2 0.0006
492 ECZEMA 32 0.0006
493 BRADYARRHYTHMIA 1 0.0006
494 DISCOMFORT 37 0.0006
495 NEAR DEATH EXPERIENCE 2 0.0006
496 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
497 ACUTE CORONARY SYNDROME 5 0.0006
498 TOXIC SKIN ERUPTION 6 0.0006
499 ENTEROBACTER INFECTION 1 0.0006
500 METASTASES TO SPINE 2 0.0006
501 COUGH 166 0.0006
502 HAEMATEMESIS 15 0.0006
503 BACTERAEMIA 7 0.0006
504 DEAFNESS BILATERAL 1 0.0006
505 BODY TEMPERATURE INCREASED 12 0.0006
506 MUSCLE RIGIDITY 7 0.0006
507 INCREASED UPPER AIRWAY SECRETION 3 0.0006
508 VIITH NERVE PARALYSIS 2 0.0006
509 BLOOD CHLORIDE INCREASED 1 0.0006
510 TREMOR 96 0.0006
511 SKIN NECROSIS 3 0.0006
512 DELIRIUM 20 0.0006
513 FORMICATION 4 0.0006
514 ERYTHEMA NODOSUM 2 0.0006
515 RESPIRATORY DISORDER 17 0.0006
516 INCONTINENCE 6 0.0006
517 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 5 0.0006
518 NYSTAGMUS 3 0.0006
519 PURPURA 5 0.0006
520 ANORECTAL DISCOMFORT 3 0.0006
521 RECTAL HAEMORRHAGE 24 0.0006
522 DERMATITIS ALLERGIC 7 0.0006
523 MUSCLE TIGHTNESS 9 0.0006
524 HYPOAESTHESIA 82 0.0005
525 VENTRICULAR ARRHYTHMIA 2 0.0005
526 CONDUCTION DISORDER 1 0.0005
527 VENTRICULAR TACHYCARDIA 9 0.0005
528 RASH GENERALISED 14 0.0005
529 HYPOXIA 19 0.0005
530 NEPHROPATHY 5 0.0005
531 HEMIPARESIS 9 0.0005
532 SNORING 2 0.0005
533 AUTOIMMUNE THYROIDITIS 2 0.0005
534 SPUTUM DISCOLOURED 5 0.0005
535 RASH 228 0.0005
536 ADRENAL DISORDER 1 0.0005
537 ARTERIAL THROMBOSIS 1 0.0005
538 CONVERSION DISORDER 1 0.0005
539 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
540 EMPYEMA 1 0.0005
541 BLOOD PRESSURE FLUCTUATION 12 0.0005
542 BRAIN INJURY 5 0.0005
543 ARTERIOSPASM CORONARY 2 0.0005
544 MIOSIS 4 0.0005
545 DEVICE RELATED SEPSIS 1 0.0005
546 CORONARY ARTERY THROMBOSIS 1 0.0005
547 CAPILLARY LEAK SYNDROME 1 0.0005
548 HYPERTHYROIDISM 7 0.0005
549 EMBOLISM 4 0.0005
550 SKIN DISORDER 16 0.0005
551 BUNDLE BRANCH BLOCK LEFT 2 0.0005
552 FOETAL DISTRESS SYNDROME 1 0.0005
553 TONGUE DISCOMFORT 2 0.0005
554 DIZZINESS 230 0.0005
555 BLOOD CREATININE INCREASED 30 0.0005
556 IMMOBILE 2 0.0005
557 URINE OUTPUT DECREASED 4 0.0005
558 HYPERKALAEMIA 16 0.0005
559 ENDOMETRIAL CANCER 1 0.0005
560 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
561 WHEELCHAIR USER 2 0.0004
562 HYPERTENSIVE CRISIS 5 0.0004
563 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
564 FACIAL PAIN 4 0.0004
565 HAEMOLYTIC ANAEMIA 4 0.0004
566 OEDEMA 24 0.0004
567 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
568 DROOLING 3 0.0004
569 EYELID DISORDER 1 0.0004
570 BRADYCARDIA 23 0.0004
571 LACTIC ACIDOSIS 14 0.0004
572 EPILEPSY 13 0.0004
573 DYSARTHRIA 16 0.0004
574 RETCHING 9 0.0004
575 COLORECTAL CANCER METASTATIC 1 0.0004
576 NERVOUS SYSTEM DISORDER 13 0.0004
577 ACUTE RESPIRATORY FAILURE 8 0.0004
578 PANIC REACTION 3 0.0004
579 VISUAL FIELD DEFECT 3 0.0004
580 RASH VESICULAR 2 0.0004
581 DYSPHAGIA 39 0.0004
582 MOUTH HAEMORRHAGE 3 0.0004
583 RESPIRATORY DEPRESSION 5 0.0004
584 RENAL TUBULAR NECROSIS 4 0.0004
585 CEREBRAL DISORDER 3 0.0004
586 NAUSEA 320 0.0004
587 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
588 SPEECH DISORDER 21 0.0004
589 RASH MACULAR 14 0.0004
590 EYELID IRRITATION 1 0.0004
591 CORONARY ARTERY STENOSIS 2 0.0004
592 DERMATOMYOSITIS 1 0.0004
593 MOTOR DYSFUNCTION 4 0.0004
594 EAR DISCOMFORT 4 0.0004
595 VISION BLURRED 52 0.0004
596 CONJUNCTIVITIS 7 0.0004
597 ADVERSE REACTION 5 0.0004
598 RENAL FAILURE ACUTE 16 0.0004
599 EYE HAEMORRHAGE 5 0.0004
600 AREFLEXIA 1 0.0004
601 CLONUS 1 0.0004
602 MUSCULOSKELETAL STIFFNESS 32 0.0004
603 ELECTRIC SHOCK SENSATION 1 0.0004
604 OCULAR DISCOMFORT 4 0.0004
605 SKIN PLAQUE 3 0.0004
606 NEUROLOGICAL SYMPTOM 2 0.0003
607 SKIN HYPERPIGMENTATION 3 0.0003
608 PRODUCT ADMINISTRATION ERROR 7 0.0003
609 STRESS CARDIOMYOPATHY 2 0.0003
610 NEUROTOXICITY 6 0.0003
611 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
612 CARDIOTOXICITY 3 0.0003
613 PULMONARY OEDEMA 15 0.0003
614 BRAIN HERNIATION 1 0.0003
615 CEREBROVASCULAR DISORDER 1 0.0003
616 CENTRAL VENOUS CATHETERISATION 1 0.0003
617 DISORIENTATION 13 0.0003
618 VULVOVAGINAL BURNING SENSATION 2 0.0003
619 SKIN DISCOLOURATION 15 0.0003
620 DYSAESTHESIA 1 0.0003
621 FIBROSIS 1 0.0003
622 CHOLANGITIS 2 0.0003
623 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
624 BLOOD CREATININE DECREASED 1 0.0003
625 MUSCULAR WEAKNESS 36 0.0003
626 BREAST CANCER RECURRENT 1 0.0003
627 RESPIRATORY FAILURE 23 0.0003
628 PNEUMOTHORAX 5 0.0003
629 METABOLIC ACIDOSIS 10 0.0003
630 SWELLING 29 0.0003
631 HEART RATE IRREGULAR 7 0.0003
632 POOR QUALITY DRUG ADMINISTERED 2 0.0003
633 ANGINA UNSTABLE 2 0.0003
634 BACTERIAL SEPSIS 1 0.0003
635 THROMBOCYTOPENIA 34 0.0003
636 CHEST PAIN 56 0.0003
637 EXPOSURE DURING BREAST FEEDING 1 0.0003
638 SKIN MASS 2 0.0003
639 ANXIETY DISORDER 1 0.0003
640 JOINT RANGE OF MOTION DECREASED 4 0.0003
641 EYELID PTOSIS 3 0.0003
642 DRY THROAT 3 0.0003
643 SUBARACHNOID HAEMORRHAGE 3 0.0003
644 BLINDNESS 12 0.0003
645 ECCHYMOSIS 2 0.0003
646 HYPERSENSITIVITY 54 0.0003
647 VENTRICULAR EXTRASYSTOLES 3 0.0003
648 TENDERNESS 3 0.0003
649 HAEMOPTYSIS 8 0.0003
650 DERMATITIS 6 0.0003
651 DEFAECATION URGENCY 2 0.0003
652 BRONCHIOLITIS 1 0.0003
653 DEPRESSED MOOD 15 0.0003
654 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
655 FIBRIN D DIMER INCREASED 1 0.0003
656 SEPSIS 31 0.0003
657 APPARENT DEATH 1 0.0003
658 PRODUCT PRESCRIBING ISSUE 6 0.0003
659 ARRHYTHMIA 13 0.0003
660 DYSSTASIA 8 0.0003
661 CUTANEOUS VASCULITIS 1 0.0003
662 ASPIRATION 3 0.0003
663 STEVENS-JOHNSON SYNDROME 6 0.0003
664 CARDIAC DYSFUNCTION 1 0.0003
665 KETOACIDOSIS 2 0.0003
666 HYDRONEPHROSIS 2 0.0003
667 CONFUSIONAL STATE 43 0.0003
668 HEPATIC FAILURE 8 0.0003
669 RHINORRHOEA 17 0.0003
670 MICTURITION URGENCY 3 0.0003
671 HAEMODYNAMIC INSTABILITY 2 0.0003
672 CARDIAC FAILURE 21 0.0003
673 PROCEDURAL COMPLICATION 2 0.0003
674 ATRIOVENTRICULAR BLOCK 2 0.0003
675 ASTHENIA 97 0.0003
676 CARDIOPULMONARY FAILURE 1 0.0003
677 HAEMORRHAGIC STROKE 2 0.0003
678 SKIN LESION 7 0.0003
679 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
680 MENTAL DISORDER 11 0.0003
681 NASAL DISCOMFORT 2 0.0003
682 MYOCLONUS 3 0.0003
683 PRODUCTIVE COUGH 12 0.0003
684 SENSORY LOSS 2 0.0002
685 CYSTITIS HAEMORRHAGIC 1 0.0002
686 SHOCK HAEMORRHAGIC 2 0.0002
687 ANGINA PECTORIS 7 0.0002
688 ARTHRITIS BACTERIAL 1 0.0002
689 BURNING SENSATION 17 0.0002
690 AORTIC DISSECTION 1 0.0002
691 PARAESTHESIA 38 0.0002
692 HEPATIC FUNCTION ABNORMAL 9 0.0002
693 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
694 GAIT INABILITY 8 0.0002
695 INFUSION SITE ERYTHEMA 2 0.0002
696 SCAR 4 0.0002
697 BLOOD POTASSIUM DECREASED 7 0.0002
698 ABNORMAL SENSATION IN EYE 1 0.0002
699 AGITATION 17 0.0002
700 MULTI-ORGAN FAILURE 4 0.0002
701 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
702 VERTIGO 14 0.0002
703 JOINT STIFFNESS 6 0.0002
704 GROIN PAIN 2 0.0002
705 METASTASES TO LIVER 4 0.0002
706 TUMOUR LYSIS SYNDROME 2 0.0002
707 LUNG INFILTRATION 2 0.0002
708 SOPOR 3 0.0002
709 EYE IRRITATION 13 0.0002
710 ISCHAEMIC STROKE 4 0.0002
711 PYREXIA 76 0.0002
712 SOMNOLENCE 44 0.0002
713 PNEUMONIA BACTERIAL 2 0.0002
714 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
715 ARTHRITIS INFECTIVE 1 0.0002
716 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
717 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
718 HYPONATRAEMIA 12 0.0002
719 EYE DISORDER 7 0.0002
720 DIALYSIS 3 0.0002
721 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
722 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
723 DIZZINESS POSTURAL 2 0.0002
724 ENCEPHALOPATHY 5 0.0002
725 APPLICATION SITE BURN 1 0.0002
726 ABDOMINAL TENDERNESS 1 0.0002
727 ANEURYSM 1 0.0002
728 ABDOMINAL PAIN LOWER 5 0.0002
729 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
730 DYSKINESIA 8 0.0002
731 SLUGGISHNESS 2 0.0002
732 NEUTROPHIL COUNT INCREASED 2 0.0002
733 ENDOCARDITIS 1 0.0002
734 MOBILITY DECREASED 14 0.0002
735 RIB FRACTURE 4 0.0002
736 DIPLOPIA 5 0.0002
737 CONVULSION 11 0.0002
738 SCRATCH 2 0.0002
739 ABDOMINAL PAIN 43 0.0002
740 GENERAL PHYSICAL HEALTH DETERIORATION 21 0.0002
741 GASTRIC ULCER HAEMORRHAGE 1 0.0002
742 BLOOD UREA INCREASED 3 0.0002
743 MALNUTRITION 2 0.0002
744 RENAL IMPAIRMENT 15 0.0002
745 ANGIOPATHY 1 0.0002
746 TINNITUS 8 0.0002
747 LETHARGY 10 0.0002
748 GASTRIC HAEMORRHAGE 2 0.0002
749 EXERCISE TOLERANCE DECREASED 1 0.0002
750 PERICARDIAL EFFUSION 4 0.0002
751 ELECTROLYTE IMBALANCE 2 0.0002
752 SPINAL PAIN 2 0.0002
753 MALAISE 74 0.0002
754 PRODUCT PRESCRIBING ERROR 4 0.0002
755 THIRST 3 0.0002
756 TOOTHACHE 3 0.0002
757 CEREBRAL INFARCTION 4 0.0002
758 LIVER INJURY 4 0.0002
759 OROPHARYNGEAL PAIN 15 0.0002
760 DRUG DIVERSION 1 0.0002
761 PHARYNGITIS 2 0.0002
762 PNEUMONIA ASPIRATION 4 0.0002
763 PHOTOPHOBIA 3 0.0002
764 POISONING 2 0.0002
765 FOREIGN BODY SENSATION IN EYES 1 0.0002
766 HYPOTHYROIDISM 5 0.0002
767 ADVERSE EVENT 14 0.0002
768 DYSGEUSIA 11 0.0001
769 HAEMATURIA 5 0.0001
770 CORONARY ARTERY OCCLUSION 2 0.0001
771 DRUG INTERACTION 23 0.0001
772 MENTAL STATUS CHANGES 4 0.0001
773 COORDINATION ABNORMAL 2 0.0001
774 RENAL FAILURE 19 0.0001
775 HYPERTENSION 30 0.0001
776 IMPAIRED WORK ABILITY 3 0.0001
777 SUBDURAL HAEMATOMA 2 0.0001
778 PARALYSIS 2 0.0001
779 BALANCE DISORDER 12 0.0001
780 ABDOMINAL DISCOMFORT 23 0.0001
781 APATHY 2 0.0001
782 ASCITES 4 0.0001
783 INFLAMMATION 7 0.0001
784 HAEMORRHAGE INTRACRANIAL 2 0.0001
785 PRODUCT QUALITY ISSUE 18 0.0001
786 HEADACHE 82 0.0001
787 HYPOKALAEMIA 6 0.0001
788 LYMPHOMA 2 0.0001
789 ANKLE FRACTURE 2 0.0001
790 BLOOD ALBUMIN DECREASED 1 0.0001
791 ATRIAL FLUTTER 1 0.0001
792 NECK PAIN 7 0.0001
793 BLOOD GLUCOSE DECREASED 6 0.0001
794 BLOOD DISORDER 1 0.0001
795 NIGHT SWEATS 4 0.0001
796 MENTAL IMPAIRMENT 3 0.0001
797 PERIPHERAL SWELLING 19 0.0001
798 OEDEMA PERIPHERAL 15 0.0001
799 INJECTION SITE URTICARIA 3 0.0001
800 MANIA 2 0.0001
801 EOSINOPHIL COUNT INCREASED 1 0.0001
802 URINARY RETENTION 4 0.0001
803 ACNE 9 0.0001
804 MUSCULOSKELETAL DISCOMFORT 2 0.0001
805 HAEMATOMA 3 0.0001
806 DEAFNESS 3 0.0001
807 LOCAL SWELLING 2 0.0001
808 MUSCLE SPASMS 21 0.0001
809 LYMPHADENOPATHY 4 0.0001
810 ATRIAL FIBRILLATION 11 0.0001
811 CEREBRAL HAEMORRHAGE 4 0.0001
812 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
813 PELVIC PAIN 2 0.0001
814 DEFORMITY 1 0.0001
815 FLANK PAIN 1 0.0001
816 EYE PAIN 6 0.0001
817 HOT FLUSH 8 0.0001
818 BLOOD SODIUM DECREASED 2 0.0001
819 HYPOCALCAEMIA 2 0.0001
820 MUSCULOSKELETAL DISORDER 2 0.0001
821 VISUAL IMPAIRMENT 13 0.0001
822 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
823 CHOLESTASIS 2 0.0001
824 PANCREATIC CARCINOMA 3 0.0001
825 DEATH 89 0.0001
826 DYSTONIA 2 0.0001
827 BODY TEMPERATURE DECREASED 1 0.0001
828 HAEMATOCRIT DECREASED 2 0.0001
829 EMPHYSEMA 1 0.0001
830 DRUG ADMINISTRATION ERROR 3 0.0001
831 SKIN BURNING SENSATION 7 0.0001
832 MYOCARDIAL INFARCTION 17 0.0001
833 LIMB DISCOMFORT 3 0.0001
834 RHABDOMYOLYSIS 4 0.0001
835 DRUG-INDUCED LIVER INJURY 3 0.0001
836 PULMONARY EMBOLISM 9 0.0001
837 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
838 BREAST PAIN 1 0.0001
839 STAPHYLOCOCCAL INFECTION 3 0.0001
840 GASTROINTESTINAL PAIN 1 0.0001
841 VISUAL ACUITY REDUCED 3 0.0001
842 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
843 TRANSAMINASES INCREASED 2 0.0001
844 NEOPLASM MALIGNANT 6 0.0001
845 HEPATOTOXICITY 2 0.0001
846 PANCREATITIS ACUTE 2 0.0001
847 CHROMATURIA 2 0.0001
848 DERMATITIS CONTACT 1 0.0001
849 DRY MOUTH 7 0.0001
850 RENAL DISORDER 4 0.0001
851 CARDIAC DISORDER 8 0.0001
852 ATAXIA 1 0.0001
853 CHOLECYSTITIS 1 0.0001
854 DRUG INTOLERANCE 8 0.0001
855 HYPOGLYCAEMIA 4 0.0001
856 C-REACTIVE PROTEIN INCREASED 3 0.0001
857 ADRENAL INSUFFICIENCY 1 0.0001
858 PANIC ATTACK 3 0.0001
859 NEURALGIA 2 0.0001
860 PLEURAL EFFUSION 5 0.0001
861 DYSPNOEA EXERTIONAL 3 0.0001
862 CELLULITIS 4 0.0001
863 UNEVALUABLE EVENT 6 0.0001
864 HEPATITIS 2 0.0001
865 ABDOMINAL PAIN UPPER 16 0.0001
866 MUCOSAL INFLAMMATION 2 0.0001
867 ANHEDONIA 2 0.0001
868 INFUSION RELATED REACTION 5 0.0001
869 JAUNDICE 2 0.0001
870 BLOOD GLUCOSE INCREASED 14 0.0001
871 PAIN OF SKIN 2 0.0001
872 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
873 BLINDNESS UNILATERAL 1 0.0001
874 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
875 RED BLOOD CELL COUNT DECREASED 2 0.0001
876 HYPOACUSIS 3 0.0001
877 SEPTIC SHOCK 3 0.0001
878 OFF LABEL USE 60 0.0001
879 CARDIOMYOPATHY 1 0.0001
880 COLON CANCER 1 0.0001
881 ABDOMINAL DISTENSION 7 0.0001
882 EPISTAXIS 5 0.0001
883 INJECTION SITE SWELLING 5 0.0001
884 DEVICE RELATED INFECTION 1 0.0001
885 FATIGUE 50 0.0001
886 ACUTE MYELOID LEUKAEMIA 1 0.0001
887 ABSCESS 1 0.0001
888 MOVEMENT DISORDER 2 0.0001
889 INTERSTITIAL LUNG DISEASE 3 0.0001
890 BLOOD POTASSIUM INCREASED 1 0.0001
891 BACK DISORDER 1 0.0001
892 COAGULOPATHY 1 0.0001
893 HEPATIC ENZYME INCREASED 4 0.0001
894 GAIT DISTURBANCE 11 0.0001
895 NERVOUSNESS 3 0.0001
896 SLEEP DISORDER 4 0.0001
897 ANXIETY 16 0.0001
898 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
899 DISTURBANCE IN ATTENTION 3 0.0001
900 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
901 HYPERGLYCAEMIA 2 0.0001
902 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
903 FEELING ABNORMAL 13 0.0001
904 FALL 18 0.0001
905 CHRONIC KIDNEY DISEASE 4 0.0001
906 PAIN 32 0.0001
907 BACK PAIN 12 0.0001
908 EAR PAIN 1 0.0001
909 OVERDOSE 11 0.0001
910 ABNORMAL BEHAVIOUR 2 0.0001
911 IRRITABILITY 3 0.0000
912 CYTOKINE RELEASE SYNDROME 1 0.0000
913 THROMBOSIS 4 0.0000
914 BONE MARROW FAILURE 1 0.0000
915 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
916 PRODUCT USE IN UNAPPROVED INDICATION 12 0.0000
917 PLATELET COUNT DECREASED 5 0.0000
918 ADVERSE DRUG REACTION 4 0.0000
919 NEPHROLITHIASIS 2 0.0000
920 COGNITIVE DISORDER 2 0.0000
921 INJURY 3 0.0000
922 PRODUCT USE ISSUE 8 0.0000
923 EMOTIONAL DISTRESS 5 0.0000
924 ABASIA 1 0.0000
925 AGEUSIA 1 0.0000
926 AGGRESSION 2 0.0000
927 HAEMOGLOBIN DECREASED 4 0.0000
928 MUSCULOSKELETAL PAIN 2 0.0000
929 GASTRITIS 1 0.0000
930 PANCREATITIS 2 0.0000
931 EAR INFECTION 1 0.0000
932 PAIN IN EXTREMITY 11 0.0000
933 ABNORMAL DREAMS 1 0.0000
934 MEDICATION ERROR 2 0.0000
935 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
936 PANCYTOPENIA 2 0.0000
937 DEMENTIA 1 0.0000
938 TOXICITY TO VARIOUS AGENTS 6 0.0000
939 SKIN EXFOLIATION 3 0.0000
940 CEREBROVASCULAR ACCIDENT 6 0.0000
941 MYALGIA 6 0.0000
942 DISEASE PROGRESSION 4 0.0000
943 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
944 GASTROINTESTINAL DISORDER 3 0.0000
945 CORONARY ARTERY DISEASE 1 0.0000
946 STOMATITIS 2 0.0000
947 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
948 EMOTIONAL DISORDER 1 0.0000
949 INJECTION SITE ERYTHEMA 4 0.0000
950 EXPOSURE DURING PREGNANCY 2 0.0000
951 CONTUSION 3 0.0000
952 AMNESIA 2 0.0000
953 FUNGAL INFECTION 1 0.0000
954 DEHYDRATION 4 0.0000
955 DRY SKIN 4 0.0000
956 INJECTION SITE PRURITUS 2 0.0000
957 NEUTROPENIA 4 0.0000
958 HAEMORRHAGE 3 0.0000
959 PNEUMONIA 9 0.0000
960 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
961 CRYING 1 0.0000
962 ACCIDENTAL OVERDOSE 1 0.0000
963 DYSURIA 1 0.0000
964 HALLUCINATION 2 0.0000
965 CONDITION AGGRAVATED 8 0.0000
966 INJECTION SITE BRUISING 2 0.0000
967 DIARRHOEA 16 0.0000
968 DRUG ABUSE 2 0.0000
969 MEMORY IMPAIRMENT 3 0.0000
970 ARTHRALGIA 9 0.0000
971 DECREASED APPETITE 5 0.0000
972 FLUID RETENTION 1 0.0000
973 ILLNESS 2 0.0000
974 ASTHMA 2 0.0000
975 FLATULENCE 1 0.0000
976 URINARY TRACT INFECTION 3 0.0000
977 JOINT SWELLING 2 0.0000
978 DEEP VEIN THROMBOSIS 1 0.0000
979 DEVICE MALFUNCTION 1 0.0000
980 INFECTION 2 0.0000
981 BRONCHITIS 1 0.0000
982 INJECTION SITE PAIN 4 0.0000
983 ARTHRITIS 1 0.0000
984 CARDIAC FAILURE CONGESTIVE 1 0.0000
985 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
986 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
987 ANAEMIA 2 0.0000
988 ALOPECIA 2 0.0000
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
990 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
991 INCORRECT DOSE ADMINISTERED 2 0.0000
992 INSOMNIA 2 0.0000
993 DEPRESSION 1 0.0000
994 DRUG INEFFECTIVE 3 0.0000